nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alphavirus RNA helper cells; Venezuelan-horse-encephalitis virus, Sindbis virus, Semliki-Forest virus attenuation and recombinant vaccine particle production in packaging cell culture
|
|
|
1997 |
15 |
4 |
p. 461- 1 p. |
artikel |
2 |
Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule—results of a post-marketing surveillance
|
Clemens, Ralf |
|
1997 |
15 |
4 |
p. 349-352 4 p. |
artikel |
3 |
Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule®): comparison with standard syringe injection
|
du Châtelet, Isabelle Parent |
|
1997 |
15 |
4 |
p. 449-458 10 p. |
artikel |
4 |
Detecting and preventing Trypanosoma cruzi infection; expression of a T. cruzi antigen and application as a recombinant vaccine or in an immunoassay for infection detection
|
|
|
1997 |
15 |
4 |
p. 461- 1 p. |
artikel |
5 |
DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice
|
He, Junkun |
|
1997 |
15 |
4 |
p. 357-362 6 p. |
artikel |
6 |
Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity
|
Baldridge, Jory R. |
|
1997 |
15 |
4 |
p. 395-401 7 p. |
artikel |
7 |
Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle
|
Matheï, Catharina |
|
1997 |
15 |
4 |
p. 402-404 3 p. |
artikel |
8 |
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a Murine tumor model
|
Carroll, Miles W. |
|
1997 |
15 |
4 |
p. 387-394 8 p. |
artikel |
9 |
Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin
|
Yang, Chunfu |
|
1997 |
15 |
4 |
p. 377-386 10 p. |
artikel |
10 |
Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines
|
Ikonomidis, Georgios |
|
1997 |
15 |
4 |
p. 433-440 8 p. |
artikel |
11 |
Large-scale production in Pichia pastoris of the recombinant vaccine Gavac™ against cattle tick
|
Canales, Mario |
|
1997 |
15 |
4 |
p. 414-422 9 p. |
artikel |
12 |
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine
|
Maiwald, H. |
|
1997 |
15 |
4 |
p. 346-348 3 p. |
artikel |
13 |
New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus
|
Wood, D.J. |
|
1997 |
15 |
4 |
p. 341-345 5 p. |
artikel |
14 |
New human cytomegalo virus peptides; peptide production for recombinant vaccine generation and virus infection diagnosis
|
|
|
1997 |
15 |
4 |
p. 461- 1 p. |
artikel |
15 |
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection
|
Weltzin, Richard |
|
1997 |
15 |
4 |
p. 370-376 7 p. |
artikel |
16 |
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T Helper Epitopes (PADRE) for antibody responses in vivo
|
del Guercio, Marie-France |
|
1997 |
15 |
4 |
p. 441-448 8 p. |
artikel |
17 |
Preparation of diphtheria vaccines using highly purified toxins
|
Relyveld, Edgar |
|
1997 |
15 |
4 |
p. 459-460 2 p. |
artikel |
18 |
Randomized, comparative trial of 20 μg vs 40 μg Engerix B vaccine in hepatitis B vaccine non-responders
|
Goldwater, Paul N. |
|
1997 |
15 |
4 |
p. 353-356 4 p. |
artikel |
19 |
Romurtide, a synthetic muramyl dipeptide derivative, promotes megakaryocytopoiesis through stimulation of cytokine production in nonhuman primates with myelosuppression
|
Namba, Kenji |
|
1997 |
15 |
4 |
p. 405-413 9 p. |
artikel |
20 |
Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174–187 from the G glycoprotein: the role of cysteinyl residues in protection
|
Simard, Claire |
|
1997 |
15 |
4 |
p. 423-432 10 p. |
artikel |
21 |
Vaccine against flavivirus infection containing recombinant envelope protein; vector expression in Saccharomyces cerevisiae and monclonal antibody for e.g. dengue virus, Japanese-encephalitis virus and yellow-fever virus infection therapy
|
|
|
1997 |
15 |
4 |
p. 461- 1 p. |
artikel |
22 |
Vaccine against human tumor; comprises a B-lymphocyte immortalized using Epstein-Barr virus and expressing the human mucin gene after plasmid pRep4MUC1 transfection
|
|
|
1997 |
15 |
4 |
p. 461- 1 p. |
artikel |
23 |
Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice
|
Hart, Mary Kate |
|
1997 |
15 |
4 |
p. 363-369 7 p. |
artikel |